Wolverine Trading, LLC Ligand Pharmaceuticals Inc Put Options Transaction History

Wolverine Trading, LLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	SELL	$94.99 - $151.56 $275,471 - $439,524	-2,900 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$127.69 - $165.85 $89,383 - $116,095	-700 Reduced 19.44%	2,900 $453,000
Q3 2021 Nov 12, 2021	BUY	$102.33 - $144.73 $368,388 - $521,027	3,600 New	3,600 $504,000
Q1 2020 May 11, 2020	SELL	$63.37 - $107.88 $766,777 - $1.31 Million	-12,100 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$96.94 - $113.59 $1.28 Million - $1.5 Million	-13,200 Reduced 52.17%	12,100 $1.26 Million
Q3 2019 Nov 14, 2019	SELL	$86.25 - $120.16 $569,250 - $793,056	-6,600 Reduced 20.69%	25,300 $2.5 Million
Q2 2019 Aug 20, 2019	SELL	$107.38 - $129.34 $2.86 Million - $3.44 Million	-26,600 Reduced 45.47%	31,900 $3.64 Million
Q1 2019 May 15, 2019	BUY	$105.93 - $142.47 $794,475 - $1.07 Million	7,500 Added 14.71%	58,500 $7.35 Million
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $6.55 Million - $13.9 Million	51,000 New	51,000 $6.93 Million
Q1 2018 May 15, 2018	SELL	$138.63 - $182.62 $346,575 - $456,550	-2,500 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$128.36 - $147.04 $89,852 - $102,928	700 Added 38.89%	2,500 $342,000
Q3 2017 Nov 15, 2017	BUY	$120.91 - $137.94 $217,638 - $248,292	1,800	1,800 $245,000

256

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.94B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.